Open Access

Phytochemical analysis, antimicrobial and antioxidant activities of Euphorbia golondrina L.C. Wheeler (Euphorbiaceae Juss.): an unexplored medicinal herb reported from Cameroon

  • Lawrence Monah Ndam1Email author,
  • Afui Mathias Mih1,
  • Aaron Suh Tening2,
  • Augustina Genla Nwana Fongod1,
  • Nkegua Anna Temenu3 and
  • Yoshiharu Fujii4

Received: 30 September 2015

Accepted: 23 February 2016

Published: 2 March 2016


This study aimed at determining the phytochemical constituents of Euphorbia golondrina L.C. Wheeler, an alien invasive medicinal herb that is used for the treatment of gastroenteritis related ailments, diabetes, conjunctivitis, gastritis, enterocolitis, tonsillitis, vaginitis, hemorrhoids, prostatism, warts and painful swellings by the Mundani people of the mount Bambouto Caldera in SouthWestern Cameroon, and to evaluate its in vitro antimicrobial and antioxidant activities. Susceptibility testing by agar well diffusion assay revealed good antibacterial activity with inhibition zone diameter of 20 ± 1.1 mm against Bacillus cereus followed by Staphylococcus aureus with inhibition zone diameter of 17 ± 1.6 mm which was significantly lower (P < 0.05) than the positive control (amoxicillin). None of the fungi was inhibited by the acetone extract of E. golondrina except Candida albicans wherein the zone of inhibition was not significantly different from that of the positive control (Amphotericin B). The ABTS scavenging activity of E. golondrina was higher than that of gallic acid and BHT at concentrations greater than 0.1 and 0.2 mg/mL respectively while at all concentrations, nitric oxide scavenging activity was higher than those of both rutin and vitamin C. GC–MS profile of E. golondrina steam distilled volatiles revealed that the plant has potent phytoconstituent classes such as sesquiterpenes, monoterpenes, alkaloids, phenolics and aromatic hydrocarbons. Among the 30 compounds identified, caryophyllene oxide (14.16 %), camphor (9.41 %) and phytol (5.75 %) were the major compounds. Further structural characterisation based on 1H and 13C NMR is required to demonstrate structural integrity including correct stereochemistry. The current study partially justifies the ethnomedicinal uses of E. golondrina in Cameroon.


Euphorbia golondrina Antioxidant activity Antimicrobial activity Phytochemicals GC–MS


Increasing trends of microbial resistance to antibiotics and various chronic and degenerative pathologies of humans caused by reactive oxygen species(ROS) have triggered the search for bioactive compounds from plants with alternative mechanisms of action to counteract pathogenic microbes and natural antioxidants capable of protecting the body against oxidative stress and free radical-induced damage (Lu et al. 2007; Mbwambo et al. 2007; N’guessan et al. 2007; Newman and Cragg 2007; Duracková 2010; Reuter et al. 2010; Davies and Davies 2010; Buffet-Bataillon et al. 2012). The plant kingdom habours enormous amounts of therapeutic agents that have diverse applications in the pharmaceutical, nutraceutical and agrochemical industries. The active principles responsible for the therapeutic effects of medicinal plants are phytochemicals, usually secondary metabolites, including but not limited to alkaloids, steroids, flavonoids, terpenoids and tannins (NONITA et al. 2010). Of the reported 500 000 species of higher plants, only about 6 and 15 % have been evaluated for biological activity and phytochemical analysis respectively (Fabricant and Farnsworth 2010; Verpoorte 2000). Over 50 % of drugs are of plant origin (Balandrin et al. 1993). The tedious process of plant–based discovery is often based on knowledge of ethnopharmacopoeia of the plant. Such medicinal plants are screened in vitro for bioactivity using several techniques. Further identification of the lead compounds is based on the diversity of secondary metabolites or phytochemicals produced by the plants.

Euphorbia golondrina L.C. Wheeler (Syn. Chamaesyce golondrina (L.C. Wheeler) Shinners) belongs to the Euphorbiaceae family and the subgenus Chamaesyce. It is an herbaceous weedy plant found in the USA, Mexico and Cameroon (Ndam et al. 2015a). In the African ethnopharmacopoeia, it is known to treat gastroenteritis related ailments (Ndam et al. 2015a). An infusion of the roots is used in the management of diabetes while a decoction of the leaves mixed with Senna alata is exploited in the treatment of conjunctivitis, gastritis, enterocolitis, tonsillitis, vaginitis, hemorrhoids, prostatism and snake poison (Aleksandroff 2011; Rodriguez, 2013). The white latex from the stem is employed as an ointment in the treatment of warts and painful swellings by the Mundani people of the mount Bambouto Caldera, SouthWestern Cameroon (Ndam et al. 2015b). There is no information on the bioactivity and the phytochemical composition of this plant. Therefore in this study, the antimicrobial activity of E. golondrina against a panel of standardized pathogenic fungi and bacteria and the antioxidant properties of the acetone crude extract of the plant were elucidated. The phytochemical screening of the plant was also done to identify the secondary metabolites occurring in it.


Plant and preparation of crude extract

The E. golondrina earlier identified (Ndam et al. 2014, 2015a) was obtained in 2015 from the mount Bambouto caldera, SouthWestern Cameroon. The fresh leaves of the plant were cut, surface sterilised with 70 % alcohol and rinsed with sterile distilled water. The leaves were air-dried at room temperature for one month, mechanically ground to a fine powder by an electrical blender and further air-dried for 3 days. One hundred grams (100 g) of the powder was macerated in 1000 mL of acetone for 48 h three times under room temperature (22–25 °C). After filtering the resultant solution through a Whatman No. 1 grade filter paper, the filtrate was then concentrated to dryness under pressure at a maximum of 40 °C using a rotary evaporator (BUCHI Rotavapor R-200, Switzerland). The concentrate was recovered with a minimum volume of dichloromethane and kept open at room temperature until all the residual solvent had evaporated. The dried crude extract was weighed, and kept in a bottle sealed with parafilm and stored at 4 °C until used. An aliquot of the extract was resuspended in acetone to yield a 100 mg/mL stock solution (Koduru et al. 2006). The yield (%, w/w) of the dried extract was calculated as: Yield (%) = (W1 × 100)/W2, where W1 is the weight of the extract after lyophilization of solvent, and W2 is the weight of the plant powder.

Microorganisms and antimicrobial susceptibility assays

The microbes used in this study were three Gram-positive bacteria: Staphylococcus aureus, Enterococcus faecalis and B. cereus and one Gram-negative bacterium (Escherichia coli). Antifungal assays were evaluated using Candida albicans, Penicillium chrysogenum, Aspergillus fumigatus, and Aspergillus niger. These microbes were chosen primarily on the basis of their importance as pathogens of humans. Pure cultures of all experimental bacteria and fungi were American Type Culture Collection (ATCC), obtained from Total Laboratory, South Africa.

Nutrient agar and Sabouraud dextrose agar (SDA) media were prepared and poured into sterilised disposable petri dishes under aseptic conditions according to the recommendations of the manufacturer. The plates were labeled and inoculated with 100 µL of 0.5 Mcfarland solutions of the respective organisms, and loaded with extract of E. golondrina (50 mg/mL) into 6 mm wells. Amoxicillin and Amphotericin B (25–50 μg/well) were used as positive controls for bacteria and fungi respectively. Each test was replicated three times. After proper incubation period at 37 °C, zones of inhibition were recorded in millimeters. The microdilution method was employed to determine the minimum inhibitory concentration (MIC) of the plant extracts using 96 well microtitre plates as previously described (Otang et al. 2012). The smallest concentration of the plant extract that was able to kill the microorganisms was considered as the minimum inhibitory concentration (MIC).

Antioxidant assays

Assay of DPPH scavenging activity

The DPPH (1,1-diphenyl-2-picrylhydrazyl) radical-scavenging activity of the test extracts was examined as previously described (Ebrahimzadeh et al. 2010). Different concentrations (0.025–0.5 μg/mL) of each extract were added, at an equal volume, to methanolic solution of DPPH (100 μM). The mixture was kept in the dark for 30 min. Vitamin C and Rutin were used as standard controls and three replications were made. After 30 min, the absorbance (A) was measured at 518 nm and converted into the percentage antioxidant activity using the following equation: % Scavenged [DPPH] = [(Ao − A1)/Ao] × 100, where Ao was the absorbance of the control and A1 was the absorbance of extract and standard.

Assay of nitric oxide scavenging activity

This assay was done according to the procedure of Ebrahimzadeh et al. (2010). Two mL of 10 mM sodium nitroprusside in 0.5 mM phosphate-buffered saline (pH 7.4) was mixed with different concentrations of the acetone extract of E. golondrina dissolved in water and incubated at 25 °C for 2.5 h. After the incubation period, 0.5 mL of Griess reagent was added and the absorbance was read at 540 nm. The Inhibition of nitric oxide radical generation was measured by comparing the absorbance value of the controls (Vitamin C and Rutin) with that of the test solution.

Reducing power assay

Different concentrations (0.025–0.05 μg/mL) of the acetone extract of the plant in distilled water were mixed with 2.5 mL of 0.2 M phosphate buffer (pH 6.6) and 2.5 mL potassium ferricyanide (1 % w/v). The mixture was then incubated at 50 °C for 20 min, and 2.5 mL of trichloroacetic acid (10 % w/v) was added. The mixture was centrifuged at 3000 rpm for 10 min. 2.5 mL of the supernatant was mixed with an equal volume of distilled water and 0.5 mL of FeCl3 (0.1 % w/v) and the absorbance was measured at 700 nm. Vitamin C and Rutin were used as positive controls.

ABTS cation free radical-scavenging activity

For ABTS (2,2′-azino-bis 3-ethylbenzothiazoline-6-sulphonic acid) assay, the procedure followed was the method of Zheleva-Dimitrova et al. (2010) and Roberta et al. (1999) with some modifications. ABTS was dissolved in water to make a concentration of 7 mmol/L. ABTS+ was produced by reacting the ABTS stock solution with 2.45 mmol/L potassium persulfate (final concentration) and the mixture was left in the dark at room temperature for 12–16 h before use. The ABTS+ stock solution was diluted with 80 % methanol to an absorbance of 0.70 ± 0.02 at 734 nm. 4.85 mL of diluted ABTS + was added to 0.15 mL of tenfold diluted samples (final concentrations 0.025–0.5 μg/mL of each extract were added, at an equal volume of dry material). The absorbance reading was taken at 6 min after the initial mixing. Gallic acid and BHT were used as positive controls. The activities of the samples were evaluated by comparison with a control (containing 4.85 mL of ABTS solution and 0.15 mL of 45 % methanol). ABTS + scavenging activity was calculated by the following formula:
$${\text{ABTS}}^{ + } \,{\text{scavenging}}\,{\text{activity}}\,(\% ) = [(Ac - As)/Ac] \times 100$$
where A C is the absorbance value of the control and A S is the absorbance value of the added samples test solution.

GC–MS analysis

Five hundred grams (500 g) of the plant sample was distilled using distilled water in an all-glass Clevenger apparatus in accordance with British Pharmacopoeia (1980). Heat was supplied to the heating mantle (50 °C) and the essential oils were extracted with 3 L of distilled water for 3 h. The oil collected was analysed using gas chromatograph-mass spectrometry (GC–MS). The GC–MS was carried out using Agilent 7890B GC system coupled to an Agilent 5977A MSD with a Zebron-5MS column (ZB-5MS 30 m × 0.25 mm × 0.25 µm) (5 %-phenylmethylpolysiloxane). GC grade helium was used as a carrier gas at a flow rate of 2 mL/min and splitless 1 µL auto-injections were used. The injection temperature was 250 °C and source temperature was 250 °C. Oven temperature was 70 °C, ramp 15 °C/min to 120 °C, ramp at 10 °C/min to 180 °C then ramp at 20 °C/min to 270 °C and hold for 3 min. Data was gathered with Chem station. The oil components were identified by matching their mass spectra and retention indices with those of the Wiley 275 library (Wiley, New York) in the computer library and literature (Siegler 1998). The yield of the oil was calculated per gram of the plant material, while the percentage composition was calculated from summation of the peak areas of the total oil composition.

Statistical analysis

The zones of inhibitions induced by the plant extract against the tested microbes were given as mean ± standard deviation of 3 replicates. Experimental results were analyzed by SPSS version 16.0 (SPSS Inc. Chicago, IL). Differences between means were determined using one-way ANOVA and least significant difference test. The level of statistical significance was set at P ≤ 0.05.


Antimicrobial activity

The extraction yield was 9.3 %. The results of the agar well diffusion assay and the MICs of the acetone extract of E. golondrina are summarised in the Table 1 and Fig. 1 below. The highest antibacterial activity with inhibition zone diameter of 20 ± 1.1 mm, MIC value of 0.01 mg/mL was observed against B. cereus, followed by S. aureus with inhibition zone diameter of 17 ± 1.6 mm, MIC value of 2.5 mg/mL, which was significantly lower (P < 0.05) than the positive control. None of the fungi was inhibited by the acetone extract of E. golondrina except C. albicans wherein the zone of inhibition (21 ± 2.1 mm) was not significantly different from that of the positive control.
Table 1

Inhibition of microbial growth by acetone extract of Euphorbia golondrina L.C. Wheeler


Zone of inhibition (mm)

Minimum inhibition concentration (mg/mL)


Positive control


Positive control



 Escherichia coli

15 ± 1.1

30 ± 0.1



 Enterococcus faecalis

15 ± 1.6

31 ± 1.1



 Staphylococcus aureus

17 ± 1.6

32 ± 3.1



 Bacillus cereus

20 ± 1.1

35 ± 0.1





 Penicillium chrysogenum


29 ± 4.1



 Aspergillus fumigatus


28 ± 2.1



 Aspergillus niger


26 ± 0.8



 Candida albicans

21 ± 2.1*

22 ± 0.8



Values are mean ± SD of triplicates experiments, Na not active

* Not significantly different from positive control (P < 0.05), positive control: Amphotericin B for fungi and amoxicillin for bacteria

Fig. 1

Susceptibility/tolerance of selected bacteria (a B. cereus; b S. aureus; c E. coli) and fungi (d C. albicans; e Aspergillus fumigates; f P. chrysogenum) to the acetone extract of Euphorbia golondrina L.C. Wheeler. Black arrow indicates zone of inhibition by extract, white arrow indicates zone of inhibition by positive control

Results of antioxidant assays

DPPH radical-scavenging activity

The results of the DPPH assay showed that the scavenging activity of Vitamin C and Rutin were higher than E. golondrina at all concentrations (Fig. 2). However, the DPPH scavenging activity of E. golondrina increased with increasing concentration.
Fig. 2

DPPH scavenging activity of the acetone extract of Euphorbia golondrina L.C. Wheeler

Nitric oxide scavenging activity

The nitric oxide (NO) scavenging activity of E. golondrina was not dose-dependent, but higher than those of both Rutin and Vitamin C (Fig. 3).
Fig. 3

Nitric oxide scavenging activity of the acetone extract of Euphorbia golondrina L.C. Wheeler

Reducing power assay

The dose–response curve for the reducing powers of the acetone extract of E. golondrina (as indicated by the absorbance at 700 nm) is shown in Fig. 4. Increased absorbance indicates increased reducing power. The reducing power of the acetone extract of E. golondrina was lower than those of both controls.
Fig. 4

Reducing power of the acetone extract of Euphorbia golondrina L.C. Wheeler

ABTS scavenging activity

Scavenging activity was expressed as percentage of inhibition of ABTS+ free radical (Fig. 5). The ABTS scavenging activity of E. golondrina was higher than that of gallic acid and BHT at concentrations greater than 0.1 and 0.2 mg/mL respectively.
Fig. 5

ABTS scavenging activity of the acetone extract of Euphorbia golondrina L.C. Wheeler

Result of the GC–MS analysis of E. golondrina

The characteristics of the phytochemicals identified, including the retention time (RT), relative peak area percentage (peak area relative to the total peak area) and chemical structures of phytoconstituents of the E. golondrina extract are summarized in Table 2. The various classes of phytochemicals in the E. golondrina plant provided the antioxidant and antimicrobial potency of the plant. Thirty compounds were identified from the steam distilled volatile of E. golondrina with caryophyllene oxide (14.16 %), camphor (9.41 %) and phytol (5.75 %) being the most abundant. These were followed by 2,6-diisopropylnaphthalene (4.77 %), octasiloxane (4.38 %), furan (3.04 %), nanonal (3.32 %), eucalyptol (2.92 %) and 3,4-dimethylanisole (2.30 %).
Table 2

Phytochemicals in Euphorbia golondrina L.C. Wheeler identified by GC–MS


Euphorbia golondrina is used to treat enterocolitis, vaginitis and conjunctivitis by the Mexicans and the Mundani people of the mount Bambouto Caldera, SouthWestern Cameroon (Ndam et al. 2015a, b; Rodriguez 2013; Aleksandroff 2011). Vaginitis is responsible for an estimated 10 million physician visits by women annually and invasion of the epithelial cells of female genitals by C. albicans causes itching and inflammation (Gibbs et al. 2009). Treatment by azoles such as fluconazole has not been effective in eradicating these infections. Hence, many women use complementary treatments (Imhof et al. 2005) with alternative medicine partly because of their fewer side effects and lower cost. The fact that the acetone extract of E. golondrina was fungicidal against C. albicans, is a partial justification of the ethnopharmacological use of the plant against vaginitis and also highlights the possibility of discovering new antifungal compounds with novel mechanisms of action from the plant. However, the inability of the acetone extract of E. golondrina to inhibit the growth of P. chrysogenum, A. fumigates, and A. niger despite its extensive use in traditional medicine is worth investigating. We hypothesise that acetone may not have extracted some of the antifungal compounds present in the plant or the medicinal compounds in the plant may have alternative modes of therapeutic action that may boost the immune system of the body.

Enterocolitis is an inflammation of the digestive tract that results in enteritis of the small intestine and colitis of the colon. Many bacteria as well as fungi and viruses are responsible for the development of enterocolitis in humans but the most common etiologic agents of the disease are: Salmonella, Shigella, E. coli, and S. aureus. Although most E. coli are commensals found in the gut of humans, some pathogenic strains are distinguished from normal flora by the possession of virulence factors such as exotoxins. The most common symptoms of enterocolitis are frequent diarrhoea, fever, vomiting and abdominal pain. S. aureus is the causative agent of acute bacterial conjunctivitis in humans, where as Streptococcus pneumoniae and Haemophilus influenzae are causative agents of conjunctivitis in children (Buznach et al. 2005). In the current study, the acetone extract of E. golondrina displayed a moderate antibacterial activity especially against E. coli, strong antibacterial activity against S. aureus and B. cereus, indicating that the plant could be a good source of antibacterial and confirming its ethnomedicinal usage in the study area against enterocolitis and conjunctivitis. Although there have been no previous reports on the antibacterial activity of E. golondrina in scientific literature, other Euphorbia species have been noted for their antibacterial activity. The ethyl acetate fraction of the methanolic extract of Euphorbia pulcherrima was reported to contain phytochemicals which showed remarkable activities against E. coli, S. aureus, Salmonella typhi, and Pseudomonas aeruginosa (Sharif et al. 2011). Methanolic extracts and latex of some species of Euphorbia are known to inhibit the growth of S. aureus, Bacillus megaterium, Proteus vulgaris, Klebsiella pneumonia, E. coli, P. aeruginosa and C. albicans (Kirbag et al. 2013).

In the Mexican ethnopharmacopoeia, E. golondrina is used to treat rheumatism while it is applied to relieve painful swellings by the Mundani people of the mount Bambouto Caldera, SouthWestern Cameroon (Ndam et al. 2015a, b; Rodriguez 2013; Aleksandroff 2011). Rheumatism is an inflammatory autoimmune disease marked by polyarthritis that is erosive, progressive and chronic. The use of E. golondrina for the traditional management of rheumatism in Cameroon suggests that antioxidants in the plant may have an important role to play as they lower the oxidative stress and the resultant inflammatory damage. In the present study, antioxidant evaluation of the acetone extract of E. golondrina was conducted using DPPH, reducing power, nitric oxide and ABTS radical scavenging assays. Potent antioxidant activity was observed during the nitric oxide and ABTS scavenging assays. The ABTS radical (ABTS·+) scavenging abilities of the acetone extract of E. golondrina were more effective than the standards; gallic acid and BHT at higher concentrations of 0.1 and 0.2 mg/mL, respectively. It was assumed that antioxidants in E. golondrina simply reduce the radical back to the parent substrate, ABTS. The radical scavenging activity of the crude extract of Euphorbia cortinifolia against ABTS showed IC50 of 95.61 ± 1.5 µg/mL, compared to the standard, BHT with IC50 of 90.91 ± 1.4 µg/mL (Hosain et al. 2014). Whilst there exist a dearth of scientific literature on the ABTS scavenging activity of Euphorbia species, this study present the first report on the ABTS scavenging activity of E. golondrina.

In the present study, the acetone extract of E. golondrina at different concentrations was assessed for nitrite free radical scavenging activity in an in vitro model. The nitric oxide scavenging activity of the acetone extract of E. golondrina was higher than that of both vitamin C and Rutin. The activity of the acetone extract could be attributed to phyto-components such as phenolic compounds. Polyphenols are major antioxidant components present in most plant extracts (Ebrahimzadeh et al. 2010). The acetone extract is thought to contain polyphenols since acetone effectively penetrates cellular membranes of plants resulting in the extraction of polyphenols (Sumazian et al. 2010). Other studies have shown that the genus Euphorbia is extremely rich in polyphenolics; 9 antioxidant polyphenols: scopoletin, scoparone, isoscopoletin, quercetin, isorhamnetin, pinocembrin, kaempferol, luteolin, and gallic acid were preliminary identified from Euphorbia hirta (Wu et al. 2012). Ferulic acid is a phenolic compound that was identified from Euphorbia tirucalli (De Araújo 2014). Boudiar et al. (2010) identified six known flavonoids namely, kaempferol, kaempferol 3-O-glucoside, kaempferol 3-rutinoside, quercetin, quercetin 3-O-glucoside, and rutin from the aerial parts of Euphorbia guyoniana. This suggests that E. golondrina might contain compounds that scavenge and this may account for the regulation of pathological conditions induced by nitric oxide and its oxidation product, peroxynitrite. Nitric oxide has been reported to be scavenged by flavonoids and saponins (Patel et al. 2010). Hence, the presence of phenolics and saponins compounds such as 1-naphthalenol and alpha-glucopyranoside could partially explain why E. golondrina is more potent at quenching the nitric oxide radical. Since chronic exposure to nitric oxide radical is associated with inflammatory diseases such as arthritis, the scavenging of E. golondrina acetone extract could partially justify the folkloric use of the plant in the treatment of rheumatism.

The GC–MS analysis of E. golondrina reveals an extremely impressive array of compounds such as caryophyllene oxide, eucalyptol, dibutylthalate, acetanilide, phenylacetamide, phytol, camphor, etc. Caryophyllene, selinene, paninsene and spathulenol are the sesquiterpenes identified in E. golondrina. Terpenoids are active against bacteria and fungi (Salari et al. 2006; Cowan 1999). Eucalyptol showed antibacterial activity against some pathogenic bacteria in the respiratory tract (Salari et al. 2006) and because of its antimicrobial properties, it is also used in dental care and soaps. Dibutylphthalate was the only phthalate that was identified from E. golondrina. Although few reports are available for the antibacterial potential of phthalate derivatives from plants, bis (2-ethylhexyl) phthalate extracted from Streptomyces bangladheshiensis has been reported to show antibacterial activity against Gram-positive bacteria while the anti-inflammatory activity of di (2-ethylhexyl) phthalate from Alchornea sp. was reported (Camila et al. 2013). Phenylacetamide (acetanilide), although no longer used as a drug, it was the first analgesic and antipyretic aniline and the success of its metabolite is well documented (Bertolini et al. 2006). The in vitro antioxidant effect of phytol including its capacity to remove hydroxyl radicals and nitric oxide has also been reported (Camila et al. 2013). Camphor is commonly used topically to relieve muscular pains especially in osteoarthritis and also for the treatment of fungal infections of the toe nail (Farhat et al. 2001). In the current study, structural characterisation of the purported compounds was limited to comparative MS spectral analysis of the steam distilled volatiles of E. golondrina. Further, structural characterisation based on 1H and 13C NMR is required to demonstrate structural integrity including correct stereochemistry which may be present in terpene compounds.


This study has demonstrated the activity of the acetone extract of E. golondrina against microorganisms of human pathogenic interest which confirms the ethnopharmacological uses of the plant. However, it was not active against Penicilium and Aspergilus which are important human pathogens and storage pathogens of plant and plant products. The extract also showed significant antioxidant properties, indicative of its potential as a source. The plethora of compounds elucidated by the GC–MS needs further investigation for possible exploitation for pharmaceutical uses.


Authors’ contributions

LMN is the main author, participated in designing the research, data collection, analysis and drafted this manuscript. AMM, AST, AGNF and YF are supervisors of this research and participated in designing the research, data collection and reviewing manuscript. NAT participated in data collection and analysis. All authors read and approved the final manuscript.


This study was financially supported by Community Career Development Foundation Cameroon (COCADEF GRANT No. 1015). The Department of Botany of the University of Fort Hares, South Africa is credited for the laboratory analysis aspect of this work. We are grateful to Mr. Babiaka Smith Borakaeyabe of the Department of Chemistry, University of Buea, Cameroon, for generating the 2D structures of the compounds.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

Department of Botany and Plant Physiology, University of Buea
Faculty of Agriculture and Veterinary Medicine, University of Buea
ABA Home Health Care Inc.
Department of International Environmental and Agricultural Sciences, Tokyo University of Agriculture and Technology


  1. Aleksandroff S (2011) Plants in the Mayan culture, 1st edn. Imago, Playal de CarmenGoogle Scholar
  2. Balandrin MF, Kinghorn AD and Farnsworth NR (1993) Plant-derived natural products in drug discovery and development: an overview human medicinal agents from plants. In: Kinghorn AD, Balandrin MF (eds) American chemical society symposium, vol 534, Washington, DC, pp 2–12Google Scholar
  3. Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S (2006) Paracetamol: new vistas of an old drug. CNS Drug Rev 12(3–4):250–275View ArticleGoogle Scholar
  4. Boudiar T, Hichem L, Khalfallah A, Kabouche A, Kabouche Z, Brouard I, Bermejo J, Bruneau C (2010) A new alkaloid and flavonoids from the aerial parts of Euphorbia guyoniana. Nat Prod Commun 5(1):35–37Google Scholar
  5. Buffet-Bataillon S, Tattevin P, Bonnaure-Mallet M, Jolivet-Gougeon A (2012) Emergence of resistance to antibacterial agents: the role of quaternary ammonium compounds—a critical review. Int J Antimicrob Agents 39:381–389View ArticleGoogle Scholar
  6. Buznach N, Dagan R, Greenberg D (2005) Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr Infect Dis J 24(9):823–828View ArticleGoogle Scholar
  7. Camila CDMPS, Salvadori MS, Mota VG, Costa LM, Antonia ACDA, Guilherme ALDO, Jéssica PC, Damião PDS, Rivelilson MDF, Reinaldo NDA (2013) Antinociceptive and antioxidant activities of phytol in vivo and in vitro models. J Neurosci 2013(2013), Article ID 949452Google Scholar
  8. Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12:564–582Google Scholar
  9. Davies J, Davies D (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74:417–433View ArticleGoogle Scholar
  10. De Araújo KM (2014) Identification of phenolic compounds and evaluation of antioxidant and antimicrobial properties of Euphorbia Tirucalli L. Antioxidants 3(1):159–175View ArticleGoogle Scholar
  11. Duracková Z (2010) Some current insights into oxidative stress. Physiol Res 59:459–469Google Scholar
  12. Ebrahimzadeh A, Nabavi SM, Nabavi SF, Bahramian F, Bekhradnia AR (2010) Antioxidant and free radical scavenging activity of H. officinalis L. var. angustifolius, V. odorata, B. hyrcana and C. speciosum. Pak J Pharm Sci 23(1):29–34Google Scholar
  13. Fabricant DS, Farnsworth NR (2010) The value of plants used in traditional medicine for drug discovery. Environ Health Perspect 109(1):69–75Google Scholar
  14. Farhat GN, Affara NI, Gali-Muhtasib HU (2001) Seasonal changes in the composition of the essential oil extract of East Mediterranean sage (Salvia libanotica) and its toxicity in mice. Toxicon 39(10):1601–1605View ArticleGoogle Scholar
  15. Gibbs RS, Danforth DN, Karlan BY, Haney AF (2009). Danforth’s obstetrics and gynecology (trans: Valdan M, Bozari B, Faghani Jadidi N). Razzagian Tehran: Arjmand: Nasle Farda (in Persian) Google Scholar
  16. Hosain H, Shaikh ER, Proity NA, Tanzir AK (2014) Determination of antioxidant activity and hplc profile of Euphorbia cotinifolia. World J Pharm Res 3(7):93–104Google Scholar
  17. Imhof M, Lipovac M, Kurz C, Barta J, Verhoeven HC, Huber JC (2005) Propolis solution for the treatment of chronic vaginitis. Int J Gynaecol Obstet 89(2):127–132View ArticleGoogle Scholar
  18. Kirbag S, Erecevit P, Zengin F, Guvenc AN (2013) Atimicrobial activities of some Euphorbia species. Afr J Tradit Complement Altern Med 10(5):305–309Google Scholar
  19. Koduru S, Grierson DS, Afolayan AJ (2006) Antimicrobial activity of Solanum aculeastrum. Pharm Biol 44:283–286View ArticleGoogle Scholar
  20. Lu Y, Zhao YP, Wang ZC, Chen SY, Fu CX (2007) Composition and antimicrobial activity of the essential oil of Actinidia macrosperma from China. Nat Prod Res 21(3):227–233View ArticleGoogle Scholar
  21. Mbwambo ZH, Moshi MJ, Masimba PJ, Kapingu MC, Nondo RS (2007) Antimicrobial activity and brine shrimp toxicity of extracts of Terminalia brownie roots and stem. BMC Complement Altern Med 7(9):1–5Google Scholar
  22. N’guessan JD, Dinzedi MR, Guessennd N, Coulibaly A, Dosso M, Djaman AJ, Guede-Guina F (2007) Antibacterial activity of the aqueous extract of Thonningia sanguinea against extended-spectrum-β-lactamases (ESBL) producing Escherichia coli and Klebsiella pneumoniae strains. Trop J Pharm Res 6(3):779–783Google Scholar
  23. Ndam LM, Mih AM, Fongod AGN, Tening AS, Tonjock RK, Enang JE, Fujii Y (2014) Phytochemical screening of the bioactive compounds in twenty (20) Cameroonian medicinal plants. Int J Curr Microbiol App Sci 3(12):768–778Google Scholar
  24. Ndam LM, Mih AM, Fongod AGN, Tening AS, Temenu NA, Fujii Y (2015a) First record of Euphorbia golondrina L. C. Wheeler (Euphorbiaceae) in Cameroon. J Biodiversity Environ Sci 6(4):428–434Google Scholar
  25. Ndam LM, Mih AM, Fongod AGN, Tening AS, Temenu NA, Fujii Y (2015b) Foliar micromorphology of Euphorbia golondrina L. C. Wheeler (Euphorbiaceae) from Cameroon. Int J Curr Res 7(7):18261–18267Google Scholar
  26. Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70(3):461–477View ArticleGoogle Scholar
  27. Nonita PP, Mylene MU (2010) Antioxidant and cytotoxic activities and phytochemical screening of four Philippine medicinal plants. J Med. Plants Res 4:407–414Google Scholar
  28. Otang WM, Grierson DS, Ndip RN (2012) Antifungal activity of Arctotis arctotoides (L.f.) O. Hoffm. and Gasteria bicolor Haw. against opportunistic fungi associated with human immunodeficiency virus/acquired immunodeficiency syndrome. Pharmacogn Mag 8(30) (ISSN: 0973-1296)Google Scholar
  29. Patel VR, Patel PR, Kaja SS (2010) Antioxidant activity of some selected medicinal plants in western region of India. Adv Biol Res 4(1):23–26Google Scholar
  30. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49(11):1603–1616View ArticleGoogle Scholar
  31. Roberta R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26:1231–1237View ArticleGoogle Scholar
  32. Rodriguez BGB (2013) Etnobotanica des Tres Municipos Del Norte del Estado Nuevo Leon, Mexico. Tesis Maestria Forestia en Ciencias Forestales. Universidad Avatonoma, Nuevo Leon, Mexico, 75 ppGoogle Scholar
  33. Salari MH, Amine G, Shirazi MH, Hafezi R, Mohammadypour M (2006) Antibacterial effects of eucalyptus globulus leaf extract on pathogenic bacteria isolated from specimens of patients with respiratory tract disorders. Clin Microbiol Infect 12(2):194–196View ArticleGoogle Scholar
  34. Sharif HB, Mukhtar MD, Mustapha Y, Lawal AO, Ekundayo FO, Adeboye CA, Ekundayo EA (2011) Antimicrobial activities and phytochemical screening of pignut (Jatrophas curcas Linn.) on some pathogenic bacteria. J Med Plants Res 5(7):1261–1264Google Scholar
  35. Siegler DS (1998) Plant secondary metabolism. Kluwer, DordretchView ArticleGoogle Scholar
  36. Sumazian Y, Syahida A, Hakiman M, Maziah M (2010) Antioxidant activities, flavonoids, ascorbic acid and phenolic contents of Malaysian vegetables. J Med Plant Res 4(10):881–890Google Scholar
  37. Verpoorte R (2000) Pharmacognosy in the new millennium: leadfinding and biotechnology. J Pharm Pharmacol 52(3):253–262View ArticleGoogle Scholar
  38. Wu Y, Qu W, Geng D, Liang JY, Luo YL (2012) Phenols and flavonoids from the aerial part of Euphorbia hirta. Chin J Nat Med 10(1):40–42View ArticleGoogle Scholar
  39. Zheleva-Dimitrova DZ, Nedialkov P, Kitanov G (2010) Radical scavenging and antioxidant activities of methanolic extracts from Hypericum species growing in Bulgaria. Pharmacogn Mag 6:74–78View ArticleGoogle Scholar


© Ndam et al. 2016